IBM model can also find molecules that bind at different sites on target proteins
An artificial intelligence (AI) model has identified potential antiviral molecules that inhibit the Sars-CoV-2 virus, from only the sequence information of target proteins – without any knowledge of the proteins’ 3D structure or known binding sites.